183 related articles for article (PubMed ID: 30397496)
1. Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus.
Matsueda Y; Arinuma Y; Nagai T; Hirohata S
Lupus Sci Med; 2018; 5(1):e000281. PubMed ID: 30397496
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
[TBL] [Abstract][Full Text] [Related]
3. Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus.
Hirohata S; Sakuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Oct; 16(5):450. PubMed ID: 25273532
[TBL] [Abstract][Full Text] [Related]
4. Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
Hirohata S; Sakuma Y; Matsueda Y; Arinuma Y; Yanagida T
Clin Exp Rheumatol; 2018; 36(6):1003-1007. PubMed ID: 29846157
[TBL] [Abstract][Full Text] [Related]
5. Role of Serum IL-6 in Neuropsychiatric Systemic lupus Erythematosus.
Hirohata S; Kikuchi H
ACR Open Rheumatol; 2021 Jan; 3(1):42-49. PubMed ID: 33393227
[TBL] [Abstract][Full Text] [Related]
6. Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus.
Sakuma Y; Nagai T; Yoshio T; Hirohata S
Mod Rheumatol; 2017 Mar; 27(2):292-297. PubMed ID: 27319578
[TBL] [Abstract][Full Text] [Related]
7. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
Asano T; Ito H; Kariya Y; Hoshi K; Yoshihara A; Ugawa Y; Sekine H; Hirohata S; Yamaguchi Y; Sato S; Kobayashi H; Migita K; Ohira H; Hashimoto Y; Watanabe H
PLoS One; 2017; 12(10):e0186414. PubMed ID: 29036223
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
[TBL] [Abstract][Full Text] [Related]
10. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
[TBL] [Abstract][Full Text] [Related]
11. Disturbance of neuron-microglia crosstalk mediated by GRP78 in Neuropsychiatric systemic lupus erythematosus mice.
Xu J; Yang C; Zeng S; Wang X; Yang P; Qin L
J Neuroinflammation; 2023 Jun; 20(1):150. PubMed ID: 37365565
[TBL] [Abstract][Full Text] [Related]
12. Brain-Reactive Antibodies are Potential Biomarkers for Evaluating Therapeutic Efficacy in NPSLE Patients.
Wang X; Feng D; Ke Y; Gu L; Lv C; Zhang M; Wang Q; Wang Y
Neuropsychiatr Dis Treat; 2022; 18():1329-1340. PubMed ID: 35813610
[TBL] [Abstract][Full Text] [Related]
13. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
14. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
16. Utility of autoantibody against an UCH-L1 epitope as a serum diagnostic marker for neuropsychiatric systemic lupus erythematosus.
Guo Y; Li X; Li R; Li Y; Wang Z; Liu H; Cao S; Li R; Zhao Y; Wang Q; Sun X
Clin Exp Rheumatol; 2022 Nov; 40(11):2078-2087. PubMed ID: 35084329
[TBL] [Abstract][Full Text] [Related]
17. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
Arinuma Y; Yanagida T; Hirohata S
Arthritis Rheum; 2008 Apr; 58(4):1130-5. PubMed ID: 18383393
[TBL] [Abstract][Full Text] [Related]
18. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
[TBL] [Abstract][Full Text] [Related]
19. Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosus.
Kondo-Ishikawa S; Fujii T; Ishigooka N; Murakami K; Nakashima R; Hashimoto M; Yoshifuji H; Tanaka M; Ohmura K; Mimori T
Lupus; 2020 Nov; 29(13):1673-1682. PubMed ID: 32883159
[TBL] [Abstract][Full Text] [Related]
20. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
Fang H; Lan L; Qu Y; Zhang Q; Lv J
J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
